Turist Financial Remains a Buy on Nuvation Bio (NUVB)

​Nuvation Bio Inc. (NYSE:NUVB) is one of the Best Small Cap Stocks Ready to Explode in 2026. On January 27, Gregory Renza from Turist Financial reiterated a Buy rating on the stock and raised the price target from $11 to $13. Earlier on January 23, Soumit Roy from JonesTrading assigned a Buy rating on Nuvation Bio Inc. (NYSE:NUVB) with a $12 price target. ​Analysts from Truist Financial noted that the increase in price target is based on the company’s Q4 2025 pre-report and the firm’s meeting with the co ...